Bain Capital acquired DSM Sinochem Pharmaceuticals for £443m.

Bain Capital acquired DSM Sinochem Pharmaceuticals, a 50/50 Joint Venture of Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and Sinochem Group for £443m. “DSP is a market leader with an international reputation for high quality products and reliability,” said Benjamin Kunstler, a Managing Director at Bain Capital Private Equity. “We believe that DSP has tremendous potential to grow organically and through acquisitions, thanks to its strong production technology, product quality, and its focus on providing pharmaceutical customers with reliable solutions to their increasingly complex supply chains. We look forward to partnering with the management team to support the company in this new stage of its development.”